📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. (2019)

First Author: FOCUS Trial Collaboration

Attributed to: MICA: Efficacy and safety evaluation of AZD1236 (Matrix metalloproteinase 9 & 12 inhibitor) in experimental stroke funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(18)32823-x

PubMed Identifier: 30528472

Publication URI: http://europepmc.org/abstract/MED/30528472

Type: Journal Article/Review

Volume: 393

Parent Publication: Lancet (London, England)

Issue: 10168

ISSN: 0140-6736